Bluebird Bio gene therapy sells itself to Carlyle and SK Capital

Sopa Images | Lightrocket | Getty Images Bluebird Bio will sell itself to private equity firms…

Goldman portfolio of hedge fund favorites is trouncing market this year

While the S & P 500 is trading close to its all-time high, a group of…

Trump could make changes to Medicare drug price negotiations

President Donald Trump arrives in the Brady Press Briefing Room at the White House on Jan.…

Bristol Myers’ stock decline in response to weak guidance is a gift to investors

Bristol Myers Squibb on Thursday reported better-than-expected quarterly results, but weak guidance for 2025 sent shares…

Vaccine stocks fall as Senate advances RFK Jr. HHS nomination

FILE PHOTO: Robert F. Kennedy Jr., U.S. President Trump’s nominee to be secretary of Health and…

Pfizer (PFE) earnings Q4 2024

Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything…

Stocks bounce back after sell-off on Trump’s tariffs, tech pressured

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon…

Reid Hoffman launches Manas AI, a new drug discovery startup

Reid Hoffman, Partner at Greylock and co-founder LinkedIn, speaks during the WSJ Tech Live conference hosted…

Your guide to the busiest week of the season

The corporate earnings season will reach its halfway point with the busiest week of the reporting…

Outlook for Feb. 3-7, 2025

Earnings season ramps up another notch next week to start February, forcing investors to wade through…